Literature DB >> 11432694

Reduced serotonin transporter binding in binge eating women.

J T Kuikka1, L Tammela, L Karhunen, A Rissanen, K A Bergström, H Naukkarinen, E Vanninen, J Karhu, R Lappalainen, E Repo-Tiihonen, J Tiihonen, M Uusitupa.   

Abstract

RATIONALE: There is evidence that abnormalities in brain dopamine, norepinephrine and serotonin metabolism may play an important role in binge eating. Serotonin-active antidepressant drugs have also been found to decrease binge eating.
OBJECTIVE: We investigated serotonin transporter binding in obese binge-eating women. Eleven obese binge-eating and seven obese control women participated in the study. The subjects were not taking any medication known to affect serotonin (5-HT) transporters.
METHODS: We used single-photon emission tomography (SPECT) with the radioligand 123I-labelled nor-beta-CIT, which specifically labels 5-HT transporters.
RESULTS: Obese binge-eating women showed significantly decreased 5-HT transporter binding in the mid-brain compared with obese controls (2.1 +/- 0.5 versus 2.9 +/- 0.5, respectively).
CONCLUSIONS: SPECT imaging with a ligand specific for 5-HT transporters can be used to assess altered serotonin transporter binding in the living human brain. The results tentatively suggest that 5-HT transporter binding is decreased in binge-eating women.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11432694     DOI: 10.1007/s002130100716

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  26 in total

1.  Treatment improves serotonin transporter binding and reduces binge eating.

Authors:  Liisa I Tammela; Aila Rissanen; Jyrki T Kuikka; Leila J Karhunen; Kim A Bergström; Eila Repo-Tiihonen; Hannu Naukkarinen; Esko Vanninen; Jari Tiihonen; Matti Uusitupa
Journal:  Psychopharmacology (Berl)       Date:  2003-05-27       Impact factor: 4.530

2.  Prevalence and correlates of binge eating in seasonal affective disorder.

Authors:  Shannon D Donofry; Kathryn A Roecklein; Kelly J Rohan; Jennifer E Wildes; Marissa L Kamarck
Journal:  Psychiatry Res       Date:  2014-03-15       Impact factor: 3.222

Review 3.  Current status of functional imaging in eating disorders.

Authors:  Guido K W Frank; Walter H Kaye
Journal:  Int J Eat Disord       Date:  2012-04-25       Impact factor: 4.861

4.  The 5HTTLPR polymorphism, prior maltreatment and dramatic-erratic personality manifestations in women with bulimic syndromes.

Authors:  Howard Steiger; Jodie Richardson; Ridha Joober; Lise Gauvin; Mimi Israel; Kenneth R Bruce; N M K Ng Ying Kin; Heidi Howard; Simon N Young
Journal:  J Psychiatry Neurosci       Date:  2007-09       Impact factor: 6.186

5.  Serotonin transporter binding after recovery from bulimia nervosa.

Authors:  Rama Pichika; Monte S Buchsbaum; Ursula Bailer; Carl Hoh; Alex Decastro; Bradley R Buchsbaum; Walter Kaye
Journal:  Int J Eat Disord       Date:  2011-06-13       Impact factor: 4.861

Review 6.  Pharmacological manipulations in animal models of anorexia and binge eating in relation to humans.

Authors:  M A van Gestel; E Kostrzewa; R A H Adan; S K Janhunen
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

Review 7.  Rapid changes in night eating: considering mechanisms.

Authors:  A Stunkard; X-Y Lu
Journal:  Eat Weight Disord       Date:  2010 Mar-Jun       Impact factor: 4.652

Review 8.  Dysregulation of brain reward systems in eating disorders: neurochemical information from animal models of binge eating, bulimia nervosa, and anorexia nervosa.

Authors:  Nicole M Avena; Miriam E Bocarsly
Journal:  Neuropharmacology       Date:  2011-11-27       Impact factor: 5.250

9.  123I-ADAM SPECT imaging of serotonin transporter binding in patients with night eating syndrome: a preliminary report.

Authors:  Jennifer D Lundgren; Andrew B Newberg; Kelly C Allison; Nancy A Wintering; Karl Ploessl; Albert J Stunkard
Journal:  Psychiatry Res       Date:  2008-02-20       Impact factor: 3.222

10.  Interaction between serotonin transporter and dopamine D2/D3 receptor radioligand measures is associated with harm avoidant symptoms in anorexia and bulimia nervosa.

Authors:  Ursula F Bailer; Guido K Frank; Julie C Price; Carolyn C Meltzer; Carl Becker; Chester A Mathis; Angela Wagner; Nicole C Barbarich-Marsteller; Cinnamon S Bloss; Karen Putnam; Nicholas J Schork; Anthony Gamst; Walter H Kaye
Journal:  Psychiatry Res       Date:  2012-11-13       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.